Both in Biotechnology
Voyager Therapeutics vs Acumen Pharmaceuticals
Over the past year VYGR returned −43.9% and ABOS returned +42.1%; their daily moves had a correlation of 0.35.
VYGR −43.9% ABOS +42.1%Growth of $1, one year, split-adjusted
| Metric | VYGR | ABOS |
|---|---|---|
| Price | $2.64 | $2.25 |
| Market cap | $162.7M | $162.4M |
| Today | −2.22% | −2.39% |
| 1 month | −25.4% | −23.1% |
| 6 months | −31.8% | +2.5% |
| Year to date | −32.8% | +6.4% |
| 1 year | −41.6% | +58.1% |
| Revenue growth (YoY) | −39.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −773.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.7× | — |
| Net cash | $116.3M | $78.6M |
| Dividend yield | — | — |
| Volatility (60d) | 46.0% | 72.1% |
| Short % of float | 7.9% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).